Valuation: Burning Rock Biotech Limited

Market Cap 63Cr 9.37Cr 8.1Cr 7.57Cr 6.94Cr 13Cr 891.65Cr 13Cr 89Cr 35Cr 446.92Cr 35Cr 34Cr 1.48TCr P/E 2024
-1.46x
P/E 2025 -27.1x
Enterprise Value 19Cr 2.88Cr 2.49Cr 2.33Cr 2.14Cr 4.02Cr 274.43Cr 4.08Cr 27Cr 11Cr 137.55Cr 11Cr 11Cr 454.74Cr EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day+1.35%
1 week-1.01%
Current month-1.01%
1 month-18.01%
3 months-46.86%
6 months-71.29%
Current year-56.28%
1 week 8.8
Extreme 8.8
9.24
1 month 8.68
Extreme 8.68
12.19
Current year 6.79
Extreme 6.79
41.72
1 year 6
Extreme 6
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
235.1
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 01/01/2014
Chief Executive Officer 48 01/01/2014
Director of Finance/CFO - 27/09/2024
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 01/06/2014
Director/Board Member 63 01/08/2016
Change 5-day change 1-year change 3-year change Capi.($)
+1.35%-1.01%+37.23%-46.28% 9.37Cr
+0.09%+2.96%+33.98%+16.37% 983.29Cr
-3.88%+9.78% - - 149.45Cr
+0.04%-5.09%+12.37%+12.60% 142.4Cr
-0.04%-7.33%-3.65%-16.26% 107.55Cr
0.00%+24.02%+70.66%+46.28% 73Cr
+1.15%+2.21%-22.71%-49.91% 60Cr
-0.12%+9.20%+98.05%+149.10% 41Cr
+0.72%-0.85%-13.34%-11.42% 41Cr
+7.53%+2.91%-49.60%-83.48% 22Cr
Average +0.68%+0.99%+18.11%+1.89% 162.91Cr
Weighted average by Cap. -0.13%+2.43%+27.89%+13.41%

Financials

2024 2025
Net sales 52Cr 7.64Cr 6.61Cr 6.17Cr 5.66Cr 11Cr 727.43Cr 11Cr 72Cr 28Cr 364.61Cr 29Cr 28Cr 1.21TCr 54Cr 8Cr 6.92Cr 6.46Cr 5.92Cr 11Cr 760.92Cr 11Cr 76Cr 30Cr 381.39Cr 30Cr 29Cr 1.26TCr
Net income -35Cr -5.14Cr -4.44Cr -4.15Cr -3.81Cr -7.16Cr -488.83Cr -7.27Cr -49Cr -19Cr -245.01Cr -19Cr -19Cr -810Cr -5.53Cr -82.01L -70.94L -66.25L -60.77L -1.14Cr -78Cr -1.16Cr -7.77Cr -3.05Cr -39Cr -3.08Cr -3.01Cr -129.33Cr
Net Debt -47Cr -7.02Cr -6.07Cr -5.67Cr -5.2Cr -9.78Cr -667.98Cr -9.94Cr -67Cr -26Cr -334.81Cr -26Cr -26Cr -1.11TCr -44Cr -6.49Cr -5.61Cr -5.24Cr -4.81Cr -9.04Cr -617.22Cr -9.18Cr -61Cr -24Cr -309.37Cr -24Cr -24Cr -1.02TCr
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
-
Date Price Change Volume
07/26/07 $8.810 -0.79% 780
06/26/06 $8.880 0.00% 1,678
05/26/05 $8.880 -1.00% 1,510
04/26/04 $8.970 +1.47% 2,910
03/26/03 $8.840 -0.67% 14,318